The use of FDG‐PET/CT to detect early recurrence after resection of high‐risk stage III melanoma-Reference-Cited by-同舟云学术

The use of FDG‐PET/CT to detect early recurrence after resection of high‐risk stage III melanoma

Published:2020-08-11 Issue:7 Volume:122 Page:1328-1336
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J Surg Oncol

Author:

Stahlie Emma H. A.¹^ORCID,Hiel Bernies²^ORCID,Stokkel Marcel P. M.²^ORCID,Schrage Yvonne M.¹^ORCID,Houdt Winan J.¹^ORCID,Wouters Michel W.¹^ORCID,Akkooi Alexander C. J.¹^ORCID

Affiliation:

1. Department of Surgical Oncology The Netherlands Cancer Institute—Antoni van Leeuwenhoek Amsterdam The Netherlands

2. Department of Nuclear Medicine The Netherlands Cancer Institute—Antoni van Leeuwenhoek Amsterdam The Netherlands

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jso.26155

Reference24 articles.

1. Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual

2. Site and Timing of First Relapse in Stage III Melanoma Patients: Implications for Follow-Up Guidelines

3. Is Surveillance Imaging Effective for Detecting Surgically Treatable Recurrences in Patients With Melanoma? A Comparative Analysis of Stage-Specific Surveillance Strategies

4. Modeled Prognostic Subgroups for Survival and Treatment Outcomes in BRAF V600–Mutated Metastatic Melanoma

5. Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma;Kelderman S;Cancer Immunol Immunother,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reconsidering S100B: Why it is time to abandon its use in detecting disease recurrence in stage III melanoma patients;European Journal of Surgical Oncology;2024-07

2. The diagnostic performance of [18F]FDG PET/CT in the detection of melanoma recurrence: a systematic review and meta-analysis;Clinical and Translational Imaging;2024-04-23

3. Diagnostic Performance of [18F]F-FDG Positron Emission Tomography (PET) in Non-Ophthalmic Malignant Melanoma: A Systematic Review and Meta-Analysis of More Than 10,000 Melanoma Patients;Cancers;2024-01-02

4. 18F-FDG PET/CT During Neoadjuvant Targeted Therapy in Prior Unresectable Stage III Melanoma Patients;Clinical Nuclear Medicine;2022-04-22

5. Follow-up of primary melanoma patients with high risk of recurrence: recommendations based on evidence and consensus;Clinical and Translational Oncology;2022-03-28